Drug Database
Back to search

Netherlands· NL-5efed99b520c

Omnipaque 300 mg I/ml, injectievloeistof

A iohexol product containing iohexol, registered in Netherlands by GE Healthcare B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC V08AB02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOmnipaque 300 mg I/ml, injectievloeis…ATCV08AB02REGISTER NO.NL-5efed99b520cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iohexolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iohexol is registered in 17 of 19 countries.

Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search iohexol products by name

Iohexol · ATC V08AB02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
IOHEXOL
Manufacturer
GE Healthcare B.V.
Country
Netherlands (NL)
ATC code
V08AB02
ATC class
Iohexol
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    09820

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

353 interactions on record for iohexol.

Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iohexol against other medicinesHow interaction checks work

Iohexol · interactions on record

353 records

  • 286 severe
  • 54 moderate
  • 13 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • ThiethylperazinA04AB03severe
  • TriflupromazinA04AD06severe
  • DronabinolA04AD10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iohexol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iohexol products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Accupaque, Iovision
  • Belgium · Omnipaque
  • Bulgaria · Kopaq, Контамедиа Йох
  • Cyprus · Omnipaque
  • Czechia · Omnipaque
  • Germany · Accupaque, Iovision
  • Estonia · Iohexol Imax, Omnipaque
  • Spain · Omnipaque
  • Finland · Omnipaque
  • France · Omnipaque
  • United Kingdom (Northern Ireland) · Iohexol Farmak Pharmaceuticals Uk, Iohexol Ge Healthcare
  • Greece · Omnipaque
  • Croatia · Omnipaque
  • Hungary · Iohexol Wogen, Omnipaque
  • Ireland · Omnipaque
  • Iceland · Omnipaque
  • Italy · Omnipaque
  • Lithuania · Iohexol Icg Farma, Iohexol Imax
  • Luxembourg · Omnipaque
  • Latvia · Iohexol Imax, Omnipaque
  • Malta · Omnipaque
  • Norway · Omnipaque
  • Poland · Omnipaque
  • Portugal · Iohexol Imax, Omnipaque
  • Romania · Omnipaque
  • Sweden · Iovision, Omnipaque
  • Slovenia · Omnipaque
  • Slovakia · Omnipaque

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3ee544a2-17e6-4908-a72d-39f51ea1b028
GET /v1/drugs/3ee544a2-17e6-4908-a72d-39f51ea1b028?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h09820_smpc.pdf",
  "strength": null,
  "atc_label": "Iohexol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg09820",
  "excipients": [
    "DINATRIUMCALCIUMEDETAAT, GEHYDRATEERD (E 385)",
    "TROMETAMOL",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "IOHEXOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h09820.pdf",
  "authorised_at": "1983/02/08",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "09820",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about iohexol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console